Company intelligence / Profile preview

Spiber

Tsuruoka, Yamagata, Japanspiber.inc ↗

Ownership: Private
Employees: ~284
Development stage: Commercial

Overview

Japan HQ has commercialized Brewed Protein™ fibers with global apparel brands such as THE NORTH FACE, sacai, PANGAIA, Woolrich, Ron Herman, Goldwin. No clinical results as the main business is not therapeutics. Swedish subsidiary has launched BioSilk products for advanced cell culture and tissue modeling research use. No clinical trials or therapeutic programs.

Modalities: Recombinant proteinBiopolymer materialsProtein-based biomaterial
Industry: Non-Drug Biotech

Partnerships

Apparel/fashion brands including THE NORTH FACE, sacai, PANGAIA, Woolrich, Ron Herman, Goldwin.Archer Daniels Midland Company (“ADM”, US) – partnership to establish mass-production plant in the US.BioLamina AB – collaboration to launch BioSilk product line for stem cell/tissue engineering markets.

Beyond the preview

Go deeper on Spiber.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Spiber.

Explore the full profile